Cancer Weekly
Susan Hasty, Publisher
Table of Contents . . . May 2nd, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Cancer Therapies - Two Potent Anticancer Weapons Developed
Colorectal Cancer - Oral Chemotherapy Demonstrates Favorable Response Rates in Advanced Cancer Patients
Esophageal Cancer - Segment Length in Barrett's Esophagus Irrelevant as Prognostic Factor
Gliomas - Iodine-131-Labeled Anti-Tenascin MAb 81C6 Therapy Evaluated
Hepatocellular Carcinoma - High Telomerase Activity Correlates with Extent of Malignancy
Intestinal Polyps - Dietary Changes Don't Prevent Recurrent Polyps; Implications for Colon Cancer
Leukemia - Bioflavonoids May Contribute to DNA Damage Leading to Disease in Infants
Lymphoma - Drug Regimen Effective for Treating Mantle-Cell Lymphoma
Metastatic Melanoma - Phase II Peptide Vaccine Trial Conducted
Oral Cancer - Drug Induces Apoptosis in Oral Cancer Cells
Pancreatic Cancer - Thoracoscopic Splanchnicectomy Can Alleviate Pain of Terminal Disease
Renal Cell Carcinoma - Combined Immunotherapy Evaluated in Metastatic Disease
Renal Cell Carcinoma - Eosinophils and C4 Predict Clinical Failure of Immunotherapy
Stroma Development - Stromas are Differentially Regulated
Burkitt's Lymphoma - Tandem-Diabodies Constructed for Immunotherapy
Colon Cancer - Genetic Immunization Aimed at Metastatic Disease
Metastases - Cancer Cells Can Be Contained from Growing at Second Site
Prostate Cancer - Milken Follows His Passion for Health onto the Internet
Renal Cell Carcinoma - Allogeneic Cell Vaccine Under Development
Anti-Angiogenesis - Kininogen Domain 5 Peptides Inhibit Angiogenesis
Cancer Immunotherapy - Phase I/II Clinical Trials Initiated for Immune Stimulants
Chronic Myelogenous Leukemia - Stem Cell Transplantation Study Gives New Hope to Adult Patients
Colorectal Cancer - Treatment Guidelines Published in Patient-Friendly Version
Pancreatic Cancer - Multi-Center Phase II Clinical Trial Announced
Patent News - Drug Shows Efficacy Against Tumors Resistant to Standard Treatment
Prostate Cancer - Surgical Simulator To Be Developed for Cryosurgical Cancer Treatment
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
